A Secreted Viral Protein Determines Norovirus Persistence By Immune Evasion
分泌的病毒蛋白通过免疫逃避决定诺如病毒的持久性
基本信息
- 批准号:10219936
- 负责人:
- 金额:$ 24.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-08-01 至 2022-07-31
- 项目状态:已结题
- 来源:
- 关键词:Advisory CommitteesAntibodiesBiological ModelsBiologyCapsidCaspaseCell LineCellsCellular TropismChildhoodCleaved cellClustered Regularly Interspaced Short Palindromic RepeatsCultured CellsCytomegalovirusDataDefectDevelopmentDevelopment PlansDiamondDisease OutbreaksDoctor of PhilosophyEducational workshopEpithelialEpithelial CellsExhibitsExtracellular SpaceFacultyGastroenteritisGenesGeneticGenetic studyGoalsGrantGrowthHumanImmune EvasionImmune systemImmunityImmunizeIn VitroInfectionInterferonsInterviewIntracellular SpaceKnock-outKoreaMediatingMembrane ProteinsMentorsMentorshipModelingMolecularMusMyeloid CellsNonstructural ProteinNorovirusOccupational activity of managing financesPassive ImmunityPatientsPhysiologicalPoint MutationPositioning AttributePostdoctoral FellowPreventionProductionProtein PrecursorsProteinsRecombinantsResearchResearch PersonnelResearch Project GrantsResearch ProposalsScienceSignal TransductionSiteSystemTestingTherapeuticTimeTraining ActivityTropismUniversitiesVaccinationVaccinesViralViral ProteinsVirulenceVirusWashingtonWorkWritingcareercareer developmentcombinatorialcytokinediarrheal diseaseenteric infectionexpression vectorfoodborne illnessimprovedin vivoin vivo Modelinhibitor/antagonistintestinal epitheliumintraperitonealmacrophagemedical schoolsmutantnovelnovel vaccinespreventresponsescreeningskillstherapeutic developmentvaccine candidatevaccine developmentvirus host interaction
项目摘要
Project Summary/Abstract
This proposal describes a four year career development plan and a research strategy for Dr. Sanghyun
Lee to transition from a postdoctoral fellow to an independent academic faculty position investigating virus-host
interactions. The overall research goal of the proposal is to elucidate the mechanism by which a secreted viral
non-structural protein antagonizes host immunity, and to evaluate this viral factor as a novel vaccine target.
Candidate: I have focused my science career on understanding virus and host interactions at both molecular
and physiological levels. In my Ph.D. work with Dr. Kwangseog Ahn at Seoul National University in Korea, I
worked on understanding the virulence of human cytomegalovirus (HCMV), and specifically focused on the
factors contributing to HCMV virulence in human patients. As a postdoc in Dr. Skip Virgin's lab at Washington
University School of Medicine, I studied the cellular tropism of norovirus and the key host immune system
determinants controlling norovirus infection in the gut.
Career Development Plan: In addition to the research proposal outlined here, I will devote approximately 15%
of my time to training activities. I will continue my professional development under the guidance of my mentor
Dr. Virgin's and my co-mentor Dr. Gaya Amarasinghe. I have assembled a career advisory committee
composed of Dr. Michael Diamond, Dr. Megan Baldridge, and Dr. Haina Shin that will evaluate and facilitate
my research progress and transition to independence. Beyond these training activities, I will prepare to
transition to an independent faculty position by improving grant-writing and interviewing skills through
workshops at WUSM, and begin planning for the new financial, management, and mentorship responsibilities
of an independent investigator.
Research Project: Human noroviruses (HNoVs) are the leading global cause of gastroenteritis. However,
there are no approved vaccines or therapeutics. With Murine norovirus (MNoV) model, we identified Tuft cells,
a rare type of intestinal epithelial cell (IEC), as the reservoir for MNoV fecal shedding and persistence. Genetic
studies revealed that viral non-structural protein NS1, rather than a viral surface protein, is the determinant of
Tuft cell tropism, and interferon-lambda (IFN-λ) to be a key host determinant. Our preliminary data suggests
that the NS1 protein is cleaved by host caspase(s) and secreted into the extracellular space, and NS1 blocks
IFN-λ production. Therefore, we hypothesize that secreted NS1 protein antagonizes IFN-λ production, and that
this antagonism is the key determinant of in vivo Tuft cell tropism. The long-term goal of this study is to
understand the molecular mechanism of NS1 secretion and IFN-λ immune evasion by MNoV, and to apply our
findings to evaluate secreted NS1 as a candidate for vaccine and therapeutic development in humans.
项目概要/摘要
该提案描述了 Sanghyun 博士的四年职业发展计划和研究策略
李将从博士后研究员转变为研究病毒宿主的独立学术教职职位
该提案的总体研究目标是阐明分泌的病毒的机制。
非结构蛋白拮抗宿主免疫,并评估这种病毒因子作为新的疫苗靶点。
候选人:我的科学生涯主要集中在理解病毒和宿主在分子层面上的相互作用
在我与韩国首尔国立大学 Kwangseog Ahn 博士的合作中,我
致力于了解人类巨细胞病毒(HCMV)的毒力,并特别关注
作为华盛顿 Skip Virgin 博士实验室的博士后,研究导致人类患者中 HCMV 毒力的因素。
大学医学院,我研究了诺如病毒的细胞趋向性和关键的宿主免疫系统
控制肠道诺如病毒感染的决定因素。
职业发展计划:除了这里概述的研究计划外,我将投入大约 15%
我将在导师的指导下继续我的职业发展。
维珍博士和我的共同导师加亚·阿马拉辛格博士组建了一个职业咨询委员会。
由 Michael Diamond 博士、Megan Baldridge 博士和 Haina Shin 博士组成,将评估和促进
我的研究进展和向独立的过渡 除了这些培训活动之外,我还将准备:
通过提高拨款写作和面试技巧,过渡到独立的教职职位
在 WUSM 举办研讨会,并开始规划新的财务、管理和指导职责
独立调查员的。
研究项目:人类诺如病毒(HNoV)是全球胃肠炎的主要原因。
没有批准的疫苗或治疗方法通过鼠诺如病毒(MNoV)模型,我们鉴定了簇细胞,
一种罕见的肠上皮细胞(IEC),作为 MNoV 粪便排出和持续存在的储存库。
研究表明,病毒非结构蛋白 NS1,而不是病毒表面蛋白,是病毒非结构蛋白 NS1 的决定因素。
我们的初步数据表明,簇细胞趋向性和干扰素-λ (IFN-λ) 是关键的宿主决定因素。
NS1 蛋白被宿主 caspase 切割并分泌到细胞外空间,并且 NS1 阻断
因此,我们努力研究分泌的 NS1 蛋白是否会拮抗 IFN-λ 的产生。
这种拮抗作用是体内簇细胞趋向性的关键决定因素。本研究的长期目标是。
了解 MNoV 分泌 NS1 和 IFN-λ 免疫逃避的分子机制,并应用我们的
评估分泌型 NS1 作为人类疫苗和治疗开发候选者的发现。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Norovirus cell tropism: The road to uncovering its secret hideout.
诺如病毒的细胞趋向性:揭开其秘密藏身处的道路。
- DOI:
- 发表时间:2022-04-13
- 期刊:
- 影响因子:30.3
- 作者:Lee; Sanghyun
- 通讯作者:Sanghyun
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sanghyun Lee其他文献
Sanghyun Lee的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sanghyun Lee', 18)}}的其他基金
Entry inhibition of SARS-CoV-2 by human LRRC15
人 LRRC15 对 SARS-CoV-2 进入的抑制
- 批准号:
10575888 - 财政年份:2023
- 资助金额:
$ 24.5万 - 项目类别:
Surfaceome CRISPR screening for SARS-CoV-2 virulent proteins
表面组 CRISPR 筛选 SARS-CoV-2 毒力蛋白
- 批准号:
10891755 - 财政年份:2022
- 资助金额:
$ 24.5万 - 项目类别:
A Secreted Viral Protein Determines Norovirus Persistence By Immune Evasion
分泌的病毒蛋白通过免疫逃避决定诺如病毒的持久性
- 批准号:
10186953 - 财政年份:2020
- 资助金额:
$ 24.5万 - 项目类别:
Surfaceome CRISPR screening for SARS-CoV-2 virulent proteins
表面组 CRISPR 筛选 SARS-CoV-2 毒力蛋白
- 批准号:
10892771 - 财政年份:2016
- 资助金额:
$ 24.5万 - 项目类别:
相似国自然基金
抗体依赖性增强效应介导非洲猪瘟病毒致病的分子机制
- 批准号:32373024
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
抗体修饰的靶向型MOF材料的构建及其诱导HER2阳性乳腺癌铜死亡协同效应的研究
- 批准号:52371256
- 批准年份:2023
- 资助金额:51 万元
- 项目类别:面上项目
抗猴痘病毒人源抗体的筛选及功能研究
- 批准号:32370992
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
AQP4抗体介导血小板炎症参与视神经脊髓炎器官局域免疫发生的机制研究
- 批准号:82371349
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
单核-巨噬细胞来源的LAMP3调控ROS通路参与抗MDA5抗体阳性皮肌炎肺间质纤维化机制研究
- 批准号:82302051
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Investigation of enterovirus D68 pathogenesis in the human spinal cord
肠道病毒 D68 在人脊髓中发病机制的研究
- 批准号:
10661096 - 财政年份:2022
- 资助金额:
$ 24.5万 - 项目类别:
Investigation of enterovirus D68 pathogenesis in the human spinal cord
肠道病毒 D68 在人脊髓中发病机制的研究
- 批准号:
10506843 - 财政年份:2022
- 资助金额:
$ 24.5万 - 项目类别:
Identifying drug synergistic with cancer immunotherapy
确定药物与癌症免疫疗法的协同作用
- 批准号:
10828594 - 财政年份:2020
- 资助金额:
$ 24.5万 - 项目类别:
Local blockade of IL10R on innate immune cells to mediate both innate and adaptive anti-tumor immunity
IL10R 对先天免疫细胞的局部阻断可介导先天和适应性抗肿瘤免疫
- 批准号:
10401840 - 财政年份:2020
- 资助金额:
$ 24.5万 - 项目类别:
Identifying drug synergistic with cancer immunotherapy
确定药物与癌症免疫疗法的协同作用
- 批准号:
10266758 - 财政年份:2020
- 资助金额:
$ 24.5万 - 项目类别: